Search research articles
Contact Us
Filters
Showing results (51-60 of 135) with videos related to
Page
of 14
Sort By:
Gynecologic Oncology
|
August 1, 1974
Adjuvant progestogen therapy in the primary definitive treatment of endometrial cancer
G C Lewis, N H Slack, R Mortel, et al.
Cancer Research
|
April 1, 1988
Heterogeneity of progesterone receptor distribution in human endometrial adenocarcinoma
R J Zaino, C L Clarke, R Mortel, et al.
AJR. American Journal of Roentgenology
|
May 1, 1976
Selective arterial embolization for control of hemorrhage in pelvic malignancy: femoral and brachial catheter approaches
F J Miller, R Mortel, W J Mann, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 1, 1986
Absence of bile acid malabsorption as a late effect of pelvic irradiation
J J Schuster, J A Stryker, L M Demers, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 1, 1979
Nuclear progestin receptors in normal and malignant human endometrium
P D Feil, W J Mann, R Mortel, et al.
Gynecologic Oncology
|
November 1, 1987
Radioimaging of human ovarian carcinoma xenograft in nude mice
A Manetta, P G Satyaswaroop, T Hamilton, et al.
Obstetrics and Gynecology
|
September 1, 1990
Recurrent Paget disease of the vulva in a split-thickness graft
J E Misas, J E Larson, E Podczaski, et al.
American Journal of Clinical Oncology
|
February 1, 1990
Aminothiadiazole (NSC 4728) in patients with advanced carcinoma of the endometrium. A phase II study of the Gynecologic Oncology group
R F Asbury, J A Blessing, W P McGuire, et al.
Gynecologic Oncology
|
June 1, 1989
Scalene lymph node biopsy in the preoperative evaluation of patients with recurrent cervical cancer
A Manetta, E S Podczaski, J E Larson, et al.
ACS Omega
|
July 7, 2025
<i>In Silico</i> and <i>In Vitro</i> Studies of Potential Novel Vitamin K Epoxide Reductase (VKOR) Inhibitors Suggest an Updated Structure-Activity Relationship
Ser Loisse R Mortel, Stephani Joy Y Macalino, Mengying Wang, et al.
Page
of 14
Search research articles
Search
Showing results (51-60 of 135) with videos related to
Sort By:
Page
of 14
Gynecologic Oncology
|
August 1, 1974
Adjuvant progestogen therapy in the primary definitive treatment of endometrial cancer
G C Lewis, N H Slack, R Mortel, et al.
Cancer Research
|
April 1, 1988
Heterogeneity of progesterone receptor distribution in human endometrial adenocarcinoma
R J Zaino, C L Clarke, R Mortel, et al.
AJR. American Journal of Roentgenology
|
May 1, 1976
Selective arterial embolization for control of hemorrhage in pelvic malignancy: femoral and brachial catheter approaches
F J Miller, R Mortel, W J Mann, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 1, 1986
Absence of bile acid malabsorption as a late effect of pelvic irradiation
J J Schuster, J A Stryker, L M Demers, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 1, 1979
Nuclear progestin receptors in normal and malignant human endometrium
P D Feil, W J Mann, R Mortel, et al.
Gynecologic Oncology
|
November 1, 1987
Radioimaging of human ovarian carcinoma xenograft in nude mice
A Manetta, P G Satyaswaroop, T Hamilton, et al.
Obstetrics and Gynecology
|
September 1, 1990
Recurrent Paget disease of the vulva in a split-thickness graft
J E Misas, J E Larson, E Podczaski, et al.
American Journal of Clinical Oncology
|
February 1, 1990
Aminothiadiazole (NSC 4728) in patients with advanced carcinoma of the endometrium. A phase II study of the Gynecologic Oncology group
R F Asbury, J A Blessing, W P McGuire, et al.
Gynecologic Oncology
|
June 1, 1989
Scalene lymph node biopsy in the preoperative evaluation of patients with recurrent cervical cancer
A Manetta, E S Podczaski, J E Larson, et al.
ACS Omega
|
July 7, 2025
<i>In Silico</i> and <i>In Vitro</i> Studies of Potential Novel Vitamin K Epoxide Reductase (VKOR) Inhibitors Suggest an Updated Structure-Activity Relationship
Ser Loisse R Mortel, Stephani Joy Y Macalino, Mengying Wang, et al.
Page
of 14